Lv4
420 积分 2023-01-16 加入
Hemorrhage from carcinoma of the lung
11个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1年前
已完结
The Retrofit: Lessons From Sotorasib's Dosing Conundrum
1年前
已完结
Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
1年前
已完结
Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs
1年前
已完结
Advancing alternative methods to reduce animal testing
1年前
已完结